Technology News and Research

RSS

Aegis Breast 3.0 that offers powerful real-time 4D image processing to be launched

Sentinelle Medical Inc., a leading manufacturer of breast MRI coils and advanced visualization software launches a suite of new leading edge clinical applications on its Aegis(TM) medical imaging software platform at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, Hall A).

26 Nov 2009

Lethality of H1N1 virus has dropped from its peak of 3.7, shows new data

Biotech firm Replikins Ltd., which has analyzed the H1N1 virus' genomic data from the 1918 pandemic through the prediction, outbreak, and progress of the current H1N1 pandemic, today issued its latest biochemical analysis of the virus.

25 Nov 2009

WHO investigates cases of H1N1 drug resistance in U.S., Britain

The WHO is looking into reports that patients with "severely suppressed immune systems" in Britain and the U.S. developed resistance Tamiflu, which is used to treat the symptoms of H1N1 (swine flu), a spokesman for the organization said Tuesday, Reuters reports.

25 Nov 2009

Agfa HealthCare establishes a healthcare technology institute in Canada

Agfa HealthCare, a leading provider of IT-enabled clinical workflow and diagnostic imaging solutions, today introduced the Agfa HealthCare Institute - a new initiative leveraging collaborative partnerships with world-class vendors, academic institutions, government and healthcare providers throughout North America to help facilitate innovation in the healthcare technology space.

25 Nov 2009

Gestion Univalor, Cognitive Sensing to commercialize Prof. Jocelyn Faubert's four products

Cutting-edge technologies are about to enter the marketplace, thanks to a new partnership between Gestion Univalor, Limited Partnership (Univalor) and Cognitive Sensing Inc. (CSI), a privately owned technology company based in Montreal.

25 Nov 2009

TomTec Imaging Systems showcases its new cardiac multimodality workstation at the RSNA

TomTec, the leading innovator for cardiac image analysis and image management, shows its new cardiac multimodality workstation at the RSNA in Chicago!

25 Nov 2009

Medtronic's strong earnings reassure defibrillator industry

Medical technology company Medtronic's stocks surged 5 percent Tuesday in the wake of strong earnings reports, while rivals on implantable cardioverter defibrillators (ICD) market saw similar gains in the neighborhood of 4 percent, Dow Jones/Wall Street Journal reports. ICDs monitor patient's hearts and shock them when they fall out of beat. The market for the devices was believed to be in a slowdown lately.

25 Nov 2009

Merge Healthcare, Insite One expand their contract to provide a universal viewing solution for archiving services

Merge Healthcare, announced today that InSite One, a leading service provider of medical data archiving, storage, and disaster-recovery solutions, has expanded its contract with Merge to provide a universal viewing solution for their InDex® archiving services.

25 Nov 2009

Emerging trends that drive the U.S. market for trauma fixation devices

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the nearly $3 billion US market for trauma fixation devices will continue to see rapid growth over the next five years despite the recent economic slowdown. MRG's US Markets for Trauma Devices 2010 report finds that this market will remain highly dynamic over the next five years, with competitors introducing specialized devices in previously underserved segments of the trauma fixation market, fueling market growth.

25 Nov 2009

Swiss investor acquires Swissray International

Swissray International, Inc. a leading manufacturer of direct digital Radiography (ddR) systems, announced today that its operations have been acquired by a private Swiss Investor with a long term view towards growing Swissray's medical imaging brand. The acquisition included all assets and intellectual property, as well as contracts and inventory.

25 Nov 2009

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.

25 Nov 2009

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

‏Dr. Sarit Larisch, Head of the Cell Death Research Laboratory and senior lecturer at the University of Haifa, has been awarded the prestigious Johnson & Johnson Focused Funding grant for her research exploring the cause of brain cell damage in Parkinson's disease.

25 Nov 2009

Merck Chimie advances to the next phase in commercializing Beads, reports CardioGenics Holdings

CardioGenics Holdings Inc., a developer of technology and products targeting the immunoassay segment of the IVD testing market, reports that Merck Chimie S.A.S. ("Merck Chimie") is progressing to the next phase of the commercialization of CardioGenics' proprietary silver coated paramagnetic Beads ("Beads").

25 Nov 2009

TSO3 and 3M continue contract negotiations; parties agree to extend timeline by Dec 21

TSO3 Inc. ("TSO3") (TSX: TOS), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that discussions with 3M continue, with the intent of signing a definitive agreement which would provide 3M with a global license and distribution rights to TSO3's STERIZONE 125L sterilizer including new cycles recently announced by TSO3.

25 Nov 2009

EGS announces closure of $21.5 million Series E financing

EndoGastric Solutions (EGS) today announced the closing of a $21.5 Million Series E financing. The funding will be used to support an expanding commercial presence for the company’s market-leading Natural Orifice Surgery (NOS) platform, which includes the EsophyX and StomaphyX surgical devices.

25 Nov 2009

NIPTE to develop educational programs on leading edge pharmaceutical technology for FDA reviewers

The U.S. Food and Drug Administration (FDA) has awarded the National Institute for Pharmaceutical Technology and Education, Inc. (NIPTE) a $652,000 two-year contract to develop and deliver a professional development program to help to ensure that FDA reviewers are current in state-of-the-art pharmaceutical manufacturing and technology.

25 Nov 2009

Study may pave way for potential drug targets in lung cancer treatment

Researchers from Boston University School of Medicine (BUSM) and the Boston University Biomedical Engineering Department have identified a number of proteins whose activation allows them to distinguish between cancer and normal cells with almost 97 percent accuracy.

25 Nov 2009

Clinical data on ImmunoGen's TAP compounds to be presented at the 51st ASH meeting

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that presentations of clinical data for three product candidates employing its Targeted Antibody Payload (TAP) technology will be made at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition to be held in New Orleans, LA, on December 5-8, 2009.

25 Nov 2009

CHMP positive opinion for marketing ELONVA in Europe

PROLOR Biotech, Inc., today noted the positive opinion by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for marketing approval in Europe for ELONVA(R), a long-acting CTP-modified version of the fertility hormone FSH from Merck & Co. Merck and PROLOR are both licensees of the CTP technology from Washington University in St. Louis.

25 Nov 2009

Third-quarter financial results announced by SemBioSys Genetics

SemBioSys Genetics Inc., specializing in the manufacture of high-value proteins and oils in plant seeds, today announced its third quarter 2009 financial and operational results.

25 Nov 2009

Technology News and Research

Aegis Breast 3.0 that offers powerful real-time 4D image processing to be launched

Lethality of H1N1 virus has dropped from its peak of 3.7, shows new data

WHO investigates cases of H1N1 drug resistance in U.S., Britain

Agfa HealthCare establishes a healthcare technology institute in Canada

Gestion Univalor, Cognitive Sensing to commercialize Prof. Jocelyn Faubert's four products

TomTec Imaging Systems showcases its new cardiac multimodality workstation at the RSNA

Medtronic's strong earnings reassure defibrillator industry

Merge Healthcare, Insite One expand their contract to provide a universal viewing solution for archiving services

Emerging trends that drive the U.S. market for trauma fixation devices

Swiss investor acquires Swissray International

Sinovac Dalian JV to research, develop, produce and commercialize human-use vaccines

Johnson & Johnson Focused Funding grant for research on brain cell damage in PD

Merck Chimie advances to the next phase in commercializing Beads, reports CardioGenics Holdings

TSO3 and 3M continue contract negotiations; parties agree to extend timeline by Dec 21

EGS announces closure of $21.5 million Series E financing

NIPTE to develop educational programs on leading edge pharmaceutical technology for FDA reviewers

Study may pave way for potential drug targets in lung cancer treatment

Clinical data on ImmunoGen's TAP compounds to be presented at the 51st ASH meeting

CHMP positive opinion for marketing ELONVA in Europe

Third-quarter financial results announced by SemBioSys Genetics

Industry Focus eBook - Cell biology (5th edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News